Edition:
India

PAVmed Inc (PAVM.OQ)

PAVM.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
1:30am IST
Change (% chg)

$0.02 (+2.59%)
Prev Close
$0.96
Open
$0.98
Day's High
$0.99
Day's Low
$0.96
Volume
9,006
Avg. Vol
30,643
52-wk High
$9.25
52-wk Low
$0.87

Latest Key Developments (Source: Significant Developments)

PAVmed Q1 Adjusted Non-GAAP Loss Per Share $0.10
Tuesday, 22 May 2018 

May 22 (Reuters) - PAVmed Inc ::PAVMED REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.10.Q1 GAAP LOSS PER SHARE $0.21.REMAIN ON TARGET TO FILE RESUBMISSION RELATED TO CARPX TO U.S. FDA BY END OF MAY.PAVMED - IDENTIFIED EU NOTIFIED BODY, TAKING ADDITIONAL REQUISITE STEPS TO SUBMIT APPLICATION FOR CE MARK FOR CARPX IN EUROPE, TARGETED FOR LATE Q3.ALSO TOOK STEPS TO INITIATE A RIGHTS OFFERING WHICH CO EXPECTS TO LAUNCH THIS WEEK.COMMON STOCK HOLDERS WILL BE GRANTED ONE RIGHT TO PURCHASE A NEW UNIT CONSISTING OF A SHARE OF STOCK AND A SERIES Z WARRANT FOR $2.25.  Full Article

PAVmed Inc Files For Non Timely 10-Q
Wednesday, 16 May 2018 

May 15 (Reuters) - PAVmed Inc ::PAVMED INC FILES FOR NON TIMELY 10-Q - SEC FILING.  Full Article

Pavmed Announces Pricing Of Firm Commitment Common Stock Offering
Friday, 19 Jan 2018 

Jan 19 (Reuters) - Pavmed Inc ::PAVMED ANNOUNCES PRICING OF FIRM COMMITMENT COMMON STOCK OFFERING.PAVMED INC - PRICING PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC OFFERING OF 2.4 MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF $1.80 PER SHARE​.  Full Article

PAVmed Sets Terms Of Previously Announced Rights Offering
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Pavmed Inc ::PAVMED SETS TERMS OF PREVIOUSLY ANNOUNCED RIGHTS OFFERING.PAVMED INC - ‍EACH RIGHT WILL ENTITLE HOLDER TO PURCHASE ONE NEW UNIT​.PAVMED INC - ‍EACH NEW UNIT WILL BE COMPRISED OF ONE SHARE OF COMMON STOCK AND ONE NEW SERIES Z WARRANT​.PAVMED INC - ‍EACH Z WARRANT WILL ENTITLE ITS HOLDER TO PURCHASE ONE SHARE OF COMMON STOCK FOR $3.00 PER SHARE FOR A PERIOD OF SIX YEARS​.PAVMED INC - ‍RIGHTS WILL BE EXERCISABLE AT A PRICE OF $2.25 PER NEW UNIT​.PAVMED INC - ‍RIGHTS WILL BE EXERCISABLE AT A PRICE OF $2.25 PER NEW UNIT​.  Full Article

Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Pavmed Inc ::PAVMED FILES 510(K) SUBMISSION WITH FDA FOR CARPX™ DEVICE TO TREAT CARPAL TUNNEL SYNDROME.PAVMED INC - ‍TARGETING CLEARANCE FOR 510(K) PREMARKET NOTIFICATION SUBMISSION FOR CARPX DEVICE IN FIRST HALF OF 2018​.  Full Article

Pavmed reports Q3 adjusted non-GAAP loss per share $0.13
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Pavmed Inc :Pavmed reports third quarter 2017 financial results.Q3 GAAP loss per share $0.40.Q3 adjusted non-GAAP loss per share $0.13.  Full Article

Pavmed offers up to 2.7 mln shares
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Pavmed Inc ::Pavmed files for offering of up to 2.7 million shares of co that may be offered for resale by selling stockholders - SEC filing.  Full Article

Pavmed reports Q2 results; provides update on carpX device
Tuesday, 16 Aug 2016 

PAVmed Inc : PAVmed Inc announces second quarter 2016 financial results and provides business update . Now initiated final design phase for commercial carpX device .To initiate formal verification, validation testing for commercial carpX device by end of year & submit 510(K) application to FDA in 2017.  Full Article

PAVmed sets Q4 timeline for FDA submission of first product
Thursday, 14 Jul 2016 

PAVmed Inc : PAVmed sets Q4 2016 timeline for FDA submission of its first product . Says it has set a Q4 2016 timeline for FDA 510(K) submission of its first product, Portio(tm) implantable vascular access device .Says looks forward to following the submission with additional product submissions and commercialization in 2017.  Full Article

BRIEF-PAVmed Announces Firm Commitment Public Offering Of Common Stock

* PAVMED ANNOUNCES FIRM COMMITMENT PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage: